Adoptive transfer of chimeric antigen receptor-transduced T cells is a promising strategy for cancer immunotherapy. The CD38 molecule. with its high expression on multiple myeloma cells. appears a suitable target for antibody therapy. https://bbmbatteryes.shop/product-category/1043/